Latest News

Add to Favorites Subscribe Share
newswise-fb-share-

Showing results

110 of 200
Newswise: Nursing Home Care Cost Significantly Outpaces General Inflation and Medical Care Prices
  • Embargo expired:
    20-Jun-2019 7:00 AM EDT

Article ID: 714539

Nursing Home Care Cost Significantly Outpaces General Inflation and Medical Care Prices

Georgetown University School of Nursing & Health Studies

One of the largest studies on out-of-pocket costs for nursing home care finds prices are high and rising faster than other medical care and consumer prices, reports a team of health policy researchers.

Released:
18-Jun-2019 3:00 PM EDT
Open in New Tab
Comment
Newswise: Indoor Tanning May Be an Addiction Abetted by Both Genetic and Psychiatric Factors
  • Embargo expired:
    11-Jun-2019 11:00 AM EDT

Article ID: 714203

Indoor Tanning May Be an Addiction Abetted by Both Genetic and Psychiatric Factors

Georgetown Lombardi Comprehensive Cancer Center

A combination of elevated symptoms of depression along with modifications in a gene responsible for dopamine activity, important to the brain’s pleasure and reward system, appear to influence an addiction to indoor tanning in young, white non-Hispanic women.

Released:
11-Jun-2019 6:05 AM EDT
Open in New Tab
Comment
Newswise: Labels of U.S. Probiotic Products Lacking, Researchers Find
  • Embargo expired:
    4-Jun-2019 12:00 PM EDT

Article ID: 713796

Labels of U.S. Probiotic Products Lacking, Researchers Find

Georgetown Lombardi Comprehensive Cancer Center

When it comes to buying probiotics, most product labels do not give consumers enough information to make an informed decision, according to a research team led by Georgetown University Medical Center.

Released:
3-Jun-2019 4:50 AM EDT
Open in New Tab
Comment
Georgetown_H_GUMC_blueRGB.jpg

Article ID: 713654

Georgetown University Launches Clinical Trial for Lewy Body Dementia

Georgetown University Medical Center

Georgetown University Medical Center announces the launch of the only known therapeutic (disease modifying) clinical trial for Lewy body dementia, a neurological disorder that affects a million people in the United States for which there are no approved medications that modify the disease.

Released:
3-Jun-2019 5:05 AM EDT
Open in New Tab
Comment

Article ID: 713458

Patient Groups Untested in Cancer Immunotherapy Trials Found to Also Benefit

Georgetown Lombardi Comprehensive Cancer Center

Cancer patients previously excluded and underrepresented in immunotherapy clinical trials, such as African Americans and patients with HIV or viral hepatitis, actually benefit at the same rate as patients tested in the clinical trials, according to a Georgetown-led study to be presented at the 2019 ASCO Annual Meeting in Chicago.

Released:
30-May-2019 5:00 AM EDT
Open in New Tab
Comment

Article ID: 713481

Significant “Knowledge Gap” Exists in Use of Genetic Testing to Decide Cancer Treatment

Georgetown Lombardi Comprehensive Cancer Center

A survey conducted by Georgetown investigators found a significant knowledge and practice gap among community oncologists in the understanding and usage of genetic testing in determining patients' treatment plans and potential clinical trial outcomes.

Released:
30-May-2019 5:00 AM EDT
Open in New Tab
Comment
Georgetown_H_GUMC_blueRGB.jpg
  • Embargo expired:
    17-May-2019 11:00 AM EDT

Article ID: 712973

For Many HIV+ Women, Daily Survival Takes Precedence Over Viral Suppression

Georgetown University Medical Center

According to scientists who study women infected with HIV, statistics often paint an impressionist view of the lives of these women that misses the granular detail that tells the real story. The imprecise big picture is that most of this population is doing a good job at suppressing the virus, but facts gathered on the ground show that many struggle with issues of daily living that can make taking a pill to keep HIV at bay difficult.

Released:
16-May-2019 8:30 AM EDT
Open in New Tab
Comment
Georgetown_H_GUMC_blueRGB.jpg

Article ID: 712972

Why Adults At Risk for Huntington’s Disease Choose Not to Learn if They Inherited Deadly Gene

Georgetown University Medical Center

As many as 90 percent of individuals who have a parent with Huntington’s disease (HD) choose not to take a gene test that reveals if they will also develop the fatal disorder — and a new study details the reasons why. Understanding the “why” matters as new clinical trials testing therapies for people who haven’t yet developed symptoms of Huntington disease requires participants to be tested for the HD gene to be included in the trials.

Released:
16-May-2019 6:05 AM EDT
Open in New Tab
Comment
Newswise: Use of Genetic Testing in Women Diagnosed with Breast Cancer Decreases Cost of Care Nationwide
  • Embargo expired:
    24-Apr-2019 12:05 AM EDT

Article ID: 711607

Use of Genetic Testing in Women Diagnosed with Breast Cancer Decreases Cost of Care Nationwide

Georgetown Lombardi Comprehensive Cancer Center

A new study suggests that Oncotype DX-guided treatment could reduce the cost for the first year of breast cancer care in the U.S. by about $50 million (about 2 percent of the overall costs in the first year). The study by Georgetown Lombardi Comprehensive Cancer Center and National Cancer Institute researchers was published April 24, in JNCI.

Released:
19-Apr-2019 10:30 AM EDT
Open in New Tab
Comment

Showing results

110 of 200

Chat now!